Pleiotropic effects of statins: the role of eicosanoid production (Q37979644)

26 August 2017

Pleiotropic effects of statins: the role of eicosanoid production (English)

1 reference

26 August 2017

1 reference

Yochai Birnbaum

1

1 reference

PubMed ID

22286195

26 August 2017

Yumei Ye

series ordinal

2

1 reference

26 August 2017

1 April 2012

1 reference

Current Atherosclerosis Reports

26 August 2017

1 reference

26 August 2017

14

1 reference

26 August 2017

135-139

1 reference

26 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-012-0232-5

26 August 2017

0 references

cites work

Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

The cardiology patient page. Statins: powerful drugs for lowering cholesterol: advice for patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Effect of a single 20-mg tablet of Atorvastatin on brachial artery blood flow in normolipidemic male smokers versus nonsmokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Regulation of the mevalonate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Rho GTPases and signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Lipidomics-based safety biomarkers for lipid-lowering treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Leukotriene D4-induced mobilization of intracellular Ca2+ in epithelial cells is critically dependent on activation of the small GTP-binding protein Rho.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Atorvastatin reduces interleukin-6 plasma concentration and adipocyte secretion of hypercholesterolemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-012-0232-5

No association of polymorphisms in the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a large central European population

21 January 2018

1 reference

12 December 2020

Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.

1 reference

12 December 2020

Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin

1 reference

12 December 2020

Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions

1 reference

12 December 2020

Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluation

1 reference

12 December 2020

Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat

1 reference

12 December 2020

10.1007/S11883-012-0232-5

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22286195